The hypermethylation of CpG island in the CGRP promoter region leads to low expression of CGRP, which affects the AKT-CREB pathway, thus promoting the development of pancreatic cancer (Figure 7). The gene discussed is CREB1; the disease is pancreatic neoplasm.